Publication | Open Access

Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy

Aldo-keto ReductaseNovel SeriesBiochemistryOrganoselenium CompoundsMedicineAnti-cancer AgentPharmacologyThioredoxin ReductaseDrug Discovery